Dermatology · Roseville, CA
NPI
1629051677
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2120 Professional Dr
Roseville, CA, 95661
Phone (916) 771-6662
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,184
34 services
Medicare patients, 2024
12
Average age 67
Drug cost, 2024
$741K
1,747 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Adam A Pettey prescribed most often to Medicare patients was Clobetasol Propionate, with 238 prescriptions and refills. In total Adam A Pettey wrote 1,747 Medicare prescriptions that cost $741K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 238 | 265 | 129 | $8,921 |
| Fluorouracil Generic | 219 | 219 | 197 | $8,580 |
| Calcipotriene Generic | 213 | 213 | 194 | $17K |
| Fluocinonide Generic | 116 | 118 | 59 | $3,278 |
| Triamcinolone Acetonide Generic | 75 | 90 | 57 | $1,740 |
| Tacrolimus Generic | 68 | 72 | 44 | $9,354 |
| Doxycycline Monohydrate Generic | 62 | 106 | 32 | $2,051 |
| Otezla Apremilast | 60 | 60 | 11 | $266K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 51 | 57 | Under 11 | $196K |
| Mupirocin Generic | 47 | 47 | 28 | $547 |
| Ketoconazole Generic | 47 | 47 | 31 | $699 |
| Hydrocortisone Generic | 46 | 46 | 30 | $537 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 45 | 51 | 26 | $2,790 |
| Metronidazole Generic | 39 | 39 | 26 | $573 |
| Pimecrolimus Generic | 34 | 34 | 15 | $4,628 |
Brand drugs: 440 claims; generic drugs: 1,307 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Adam A Pettey were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.